Is Lemborexant safe to take half a tablet?
Lemborexant tablets are usually fixed-dose, and whether the tablet can be safely divided into halves depends on the drug's formulation design and disintegration characteristics. Some patients can try half a tablet under the guidance of a doctor to adjust the efficacy or improve tolerance. However, it must be noted that splitting the tablet in half without authorization may affect the drug release rate and bioavailability, resulting in unstable or insufficient efficacy. The use of half a tablet is mainly suitable for patients with mild insomnia or elderly patients. Doctors will adjust the dosage according to the severity of the individual's sleep disorder, weight, age and concomitant diseases, and closely monitor the efficacy and potential side effects.
In clinical practice, if a doctor recommends trying half a tablet, he or she will usually evaluate the patient's sleep structure, mental state the next day, and drug tolerance. When patients initially use half a tablet, they should record in detail the time it takes to fall asleep, the number of nighttime awakenings and the overall sleep quality, and provide timely feedback to the doctor so that the dose can be adjusted or restored to the standard dose. Halving or increasing the dose without medical guidance may result in poor efficacy and even increase the risk of drug side effects, such as daytime drowsiness, decreased concentration, or dizziness.
In general, leborexan is a new type of orexin receptor antagonist with high safety and stable effect in treating insomnia. However, the use of half a tablet must be done under the guidance of a doctor to ensure efficacy and safety. Reasonable dose adjustment combined with sleep hygiene education and lifestyle intervention can optimize the efficacy, improve the patient's overall quality of life, and achieve safe and effective individualized treatment. Patients should follow the doctor's instructions during use and have regular follow-up visits and evaluations to ensure that the treatment achieves the best effect. The introduction of this drug not only meets patients' needs for safe non-benzodiazepine drugs, but also promotes the development and practice of domestic sleep medicine.
Reference materials:https://medlineplus.gov/druginfo/meds/a620039.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)